Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of the CYP2C19 polymorphism in a North-eastern Thai population.

Pharmacogenetics - 1 Apr 2002

Tassaneeyakul Wichittra, Tawalee Arporn, Tassaneeyakul Wongwiwat, Kukongviriyapan Veerapol, Blaisdell Joyce, Goldstein Joyce A, Gaysornsiri Dhanu

Abstract excerpt

CYP2C19 is a polymorphically expressed cytochrome P450 responsible for the metabolism of several clinically used drugs, including some barbiturates, diazepam, proguanil, propranolol and several proton pump inhibitors. Genetic polymorphism of this enzyme shows marked interracial differences, with the poor metabolizer (PM) phenotype representing 2-5% of Caucasian and 11-23% of Oriental populations. In the present...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aryl Hydrocarbon Hydroxylases
Share to Cytochrome P-450 CYP2C19

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cytochrome P-450 Enzyme System

Share to Genetics, Population

Share to Mixed Function Oxygenases

Share to Omeprazole

Share to Polymerase Chain Reaction

Share to Thailand

Source

Identifiers

PMID: 11927837
DOI: 10.1097/00008571-200204000-00006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of the CYP2C19 polymorphism in a North-eastern Thai population.PMID 11927837Read ↗

Allele frequencies of single nucleotide polymorphisms of clinically important drug-metabolizing enzymes CYP2C9, CYP2C19, and CYP3A4 in a Thai population.Semantic proximity Read ↗

CYP2C19 genetic polymorphism in Thai, Burmese and Karen populations.Semantic proximity Read ↗

The effect of the CYP2C19 genotype on the hydroxylation index of omeprazole in South Indians.Semantic proximity Read ↗

[Genetic polymorphism of the CYP2C subfamily].Semantic proximity Read ↗

CYP2C19 genetic mutations in North Indians.Semantic proximity Read ↗

Cyp2c19 genotype and omeprazole hydroxylation phenotype in Chinese Li population.Semantic proximity Read ↗

Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations.Semantic proximity Read ↗

Hydroxylation index of omeprazole in relation to CYP2C19 polymorphism and sex in a healthy Iranian population.Semantic proximity Read ↗

Genetic polymorphism of the hepatic cytochrome P450 2C19 in north Indian subjects.Semantic proximity Read ↗

Genotype‑phenotype analysis of CYP2C19 in the Tibetan population and its potential clinical implications in drug therapy.Semantic proximity Read ↗

CYP2C19 genotype and phenotype determined by omeprazole in a Korean population.Semantic proximity Read ↗

Genetic polymorphism of CYP2C19 and lansoprazole pharmacokinetics in Japanese subjects.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.